These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2057422)

  • 21. Hematologic abnormalities in patients with endocrine and metabolic disorders.
    Orwoll ES; Orwoll RL
    Hematol Oncol Clin North Am; 1987 Jun; 1(2):261-79. PubMed ID: 3308823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Humoral hypercalcemia in neoplasias: role of parathyroid hormone related peptide (PTH-rp)].
    Gardin JP; Paillard M
    Rev Prat; 1991 Feb; 41(4):347-9. PubMed ID: 2008586
    [No Abstract]   [Full Text] [Related]  

  • 23. HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE.
    BENOIT FL; THEIL GB; WATTEN RH
    Metabolism; 1963 Dec; 12():1072-82. PubMed ID: 14100279
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercalcemia in malignancy.
    Strewler GJ; Nissenson RA
    West J Med; 1990 Dec; 153(6):635-40. PubMed ID: 2293469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone-related protein mediates hypercalcemia in an exocrine pancreatic cancer.
    Tachibana I; Nakano S; Akiyama T; Ogami Y; Tabaru A; Otsuki M
    Am J Gastroenterol; 1994 Sep; 89(9):1580-1. PubMed ID: 8079945
    [No Abstract]   [Full Text] [Related]  

  • 28. Bisphosphonates and primary hyperparathyroidism.
    Rodan GA
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Urinary excretion of hydroxyproline as an index of systemic collagen metabolism].
    Drozdz M; Kucharz E
    Pol Tyg Lek; 1972 Oct; 27(42):1655-7. PubMed ID: 4564011
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
    Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
    Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
    Body JJ; Dumon JC; Thirion M; Cleeren A
    J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
    Blind E; Raue F; Meinel T; Wüster C; Ziegler R
    Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Achievements in endocrinology].
    Hartwig W
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):495-500. PubMed ID: 1981093
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endocrine factors in dental development].
    Job JC; Mugnier A
    Rev Fr Odontostomatol; 1969 May; 16(5):625-34. PubMed ID: 5257247
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein.
    Loh K; Matthay KK; Hoover M; Bracho FA; Cortez AB; Conte FA; Albanese CT; Miller TR; Price DC; Flores AJ; Kaviani A; Shoback D
    Horm Res; 1998; 50(4):217-21. PubMed ID: 9838243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of hyperthyroidism in patients receiving thyroid hormone.
    Dymling JF; Becker DV
    J Clin Endocrinol Metab; 1967 Oct; 27(10):1487-91. PubMed ID: 4168316
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bone hyperresorption in neoplastic diseases. Foreword].
    Vinceneux P
    Presse Med; 2000 Mar; 29(9):485-6. PubMed ID: 10745941
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypercalcemia (with treatment)].
    Prié D
    Rev Prat; 2006 Oct; 56(16):1827-33. PubMed ID: 17315511
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of growth hormone treatment in girls with Turner syndrome].
    Rongen-Westerlaken C
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():31-2. PubMed ID: 3413772
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.